Dr. Adeola R. Uthman, MD

Dr. Uthman practices at St. John's Episcopal Hospital in Far Rockaway, New York, part of Episcopal Health Services.

Dr. Uthman's NPI, 1649204959, was assigned on July 10, 2006. Dr. Uthman holds New York license 210407.

Dr. Uthman's primary practice is St. John's Episcopal Hospital, at 327 Beach 19th Street, Far Rockaway, NY 11691 in Queens County. The practice phone is (718) 869-7000.

Dr. Uthman's primary practice is St. John's Episcopal Hospital in Far Rockaway, New York, part of Episcopal Health Services. Dr. Uthman is also affiliated with North Shore University Hospital. The medical group on file is Provider Partners. Dmand AI also links Dr. Uthman to 1 more hospital, 3 medical groups, 2 group practices and clinics, 2 skilled nursing facilities, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uthman practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Uthman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Uthman is licensed in New York.

CMS data shows 4,518 Medicare services from Dr. Uthman across 15 procedure codes in 2024, for 1,313 Medicare patients. Medicare paid $255,884 for them.

CMS counts 1,313 Medicare patients who saw Dr. Uthman in 2024. The largest group is 65 to 74, with 460 patients. 75% of them have diabetes, and 75% have high blood pressure. 82% are also on Medicaid. Their average risk score is 3.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uthman's median patient age at 63, with 53% women.

In 2024, Dr. Uthman wrote 7,975 Medicare Part D claims for 225 patients. 75% of them were for generic drugs. CMS names the drug for 7,409 of them, across 120 drugs with 11 or more claims each, at $1,578,892 in total drug cost. In 2023, CMS named 6,930 claims across 119 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Uthman for performance year 2024, reported individually. Dr. Uthman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 42 general payments to Dr. Uthman from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $359.